Screening for metastatic osteosarcoma biomarkers with a DNA microarray

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 4, 2014, Pages 1817-1822

  Diao, Chun Yu ^a   Guo, Hong Bing ^a   Ouyang, Yu Rong ^a   Zhang, Han Cong ^a   Liu, Li Hong ^a   Bu, Jie ^a   Wang, Zhi Hua ^b   Xiao, Tao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Chenzhou No 1 People's Hospital   (China)

Author keywords

Differential gene expression; Functional enrichment; Metastatic osteosarcoma; MiRNA; Regulatory network

Indexed keywords

CALMODULIN BINDING PROTEIN; MICRORNA; MIRN202 MICRORNA, HUMAN; MIRN9 MICRORNA, HUMAN; STX1A PROTEIN, HUMAN; SYNTAXIN 1; TRANSCRIPTOME; TUMOR MARKER;

ARTICLE; BONE TUMOR; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PROTEIN PROTEIN INTERACTION;

BONE NEOPLASMS; CALMODULIN-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; PROTEIN INTERACTION MAPS; SYNTAXIN 1; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84896934420     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.4.1817     Document Type: Article

References (39)

1. Amsellem V, Kryszke MH, Hervy M, et al (2005). The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Exp Cell Res, 304, 443-56.
2. Bao Y-P, Yi Y, Peng L-L, et al (2013). Roles of microRNA-206 in osteosarcoma pathogenesis and progression. Asian Pac J Cancer Prev, 14, 3751-5.
3. Benjamini Y (2010). Discovering the false discovery rate. J R Stat Soc Series B Stat Methodol, 72, 405-16.
4. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol, 289-300.
5. Breitkreutz BJ, Stark C, Tyers M (2003a). The GRID: The general repository for interaction datasets. Genome Biol, 4, R23.
6. Breitkreutz BJ, Stark C, Tyers M (2003b). Osprey: a network visualization system. Genome Biol, 4, R22.
7. Cuomo M E, Knebel A, Platt G, et al (2005). Regulation of microfilament organization by Kaposi sarcoma-associated herpes virus-cyclin· CDK6 phosphorylation of caldesmon. J Biol Chem, 280, 35844-58.
8. Densmore C L, Kleinerman ES, Gautam A, et al (2001). Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes. Cancer Gene Therapy, 8, 619-27.
9. Di Cristofano C, Leopizzi M, Miraglia A, et al (2010). Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell. Mod Pathol, 23, 1012-20.
10. Duncan D, Prodduturi N, Zhang B (2010). WebGestalt2: an updated and expanded version of the Web-based Gene Set Analysis Toolkit. Bmc Bioinformatics, 11, P10.
11. Emmrich S, Katsman-Kuipers J, Henke K, et al (2013). miR-9 is a tumor suppressor in pediatric AML with t (8; 21). Leukemia, ????????
12. Fan WD, Zhang XQ, Guo HL, et al (2012). Bioinformatics analysis reveals connection of squamous cell carcinoma and adenocarcinoma of the lung. Asian Pac J Cancer Prev, 13, 1477-82.
13. Ferrari S, Smeland S, Mercuri M, et al (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol, 23, 8845-52.
14. Hoffman A E, Liu R, Fu A, et al (2013). Targetome profiling, pathway analysis and genetic association study implicate miR-202 in lymphomagenesis. Cancer Epidemiol Biomarkers Prev, 22, 327-36.
15. Hu S, Xu C, Guan W, et al (2013). Texture feature extraction based on wavelet transform and gray-level co-occurrence matrices applied to osteosarcoma diagnosis. Biomed Mater Eng, 23, S129-S43.
16. Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc, 4, 44-57.
17. Huang G, Nishimoto K, Zhou Z, et al (2012). miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res, 72, 908-16.
18. Hwang W, Cho YR, Zhang A, Ramanathan M (2006). A novel functional module detection algorithm for protein-protein interaction networks. Algorithms Mol Biol, 1, 24.
19. Jones K B, Salah Z, Del Mare S, et al (2012). miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res, 72, 1865-77.
20. Khew-Goodall Y, Goodall GJ (2010). Myc-modulated miR-9 makes more metastases. Nat Cell Biol, 12, 209-11.
21. Lau SK, Boutros PC, Pintilie M, et al (2007). Three-gene prognostic classifier for early-stage non-small-cell lung cancer. J Clin Oncol, 25, 5562-9.
22. Lu J, Luo H, Liu X, et al (2013). miR-9 targets CXCR4 and functions as a potential tumor suppressor in nasopharyngeal carcinoma. Carcinogenesis, ????????.
23. Ma L, Young J, Prabhala H, et al (2010). miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol, 12, 247-56.
24. Ragland BD, Bell WC, Lopez RR, Siegal GP (2002). Cytogenetics and molecular biology of osteosarcoma. Lab Invest, 82, 365-73.
25. Rao-Bindal K, Rao CK, Yu L, Kleinerman ES (2012). Expression of c-FLIP in pulmonary metastases in osteosarcoma patients and human xenografts. Pediatr Blood Cancer, 60, 575-9.
26. Ren L, Hong S, Cassavaugh J, et al (2008). The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC. Oncogene, 28, 792-802.
27. Salinas-Souza C, De Oliveira R, Alves MT, et al (2013). The metastatic behavior of osteosarcoma by gene expression and cytogenetic analyses. Hum Pathol, 44, 2188-98.
28. Smyth GK (2005). Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. Springer.
29. Smyth GK, Speed T (2003). Normalization of cDNA microarray data. Methods, 31, 265-73.
30. Sun C, Li N, Yang Z, et al (2013). mir-9 regulation of BrcA1 and Ovarian cancer Sensitivity to cisplatin and PArP inhibition. J Natl Cancer Inst, 105, 1750-8.
31. Tanay A, Sharan R, Kupiec M, Shamir R (2004). Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc Natl Acad Sci USA, 101, 2981-6.
32. Thorsen K, Sørensen KD, Brems-Eskildsen AS, et al (2008). Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis. Mol Cell Proteomics, 7, 1214-24.
33. Tsao MS, Lau S, Boutros P, et al (2011). Materials and methods for prognosing lung cancer survival. Google Patents.
34. Willis RC, Hogue CW (2006). Searching, viewing, and visualizing data in the Biomolecular Interaction Network Database (BIND). Curr Protoc Bioinformatics, Chapter 8: Unit 8.9.
35. Zhang B, Kirov S, Snoddy J (2005). WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res, 33, W741-8.
36. Zhang B, Pan X, Cobb GP, Anderson TA (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol, 302, 1-12.
37. Zhang H, Cai X, Wang Y, et al (2010). microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol Rep, 24, 1363-9.
38. Zhao Y, Li C, Wang M, et al (2013). Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer. PloS One, 8, e69756.
39. Zhou G, Shi X, Zhang J, et al (2013). MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review. J Int Med Res, 41, 1-12.